The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Sinnreich Matthew Phillip since 2022.
This trader's CIK number is 1939708.
At the time of last reporting, Sinnreich Matthew Phillip was the President and Acting CEO of Organicell Regenerative Medicine, Inc.. (stock ticker symbol OCEL).
Also see all insider trading activities at Organicell Regenerative Medicine, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2022 | OCEL | 0 | $0 | 20,000 | $800 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-10-13 | OCEL | Sale | 20,000 | .04 | 800 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Sinnreich Matthew Phillip (President and Acting CEO of Organicell Regenerative Medicine, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.